Stay updated on Nivolumab for Recurrent Meningioma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Recurrent Meningioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Recurrent Meningioma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and v3.4.2 was removed. No substantive changes to the study information or documents are visible.
    Difference
    0.0%
    Check dated 2026-03-11T23:46:44.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    A new site revision note (v3.4.2) was added and older notices/revisions (including a government funding status notice and revision v3.4.1) were removed. There is no impact on the study content or the information presented about the trial.
    Difference
    0.4%
    Check dated 2026-02-11T14:20:58.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding affecting information timeliness and response to inquiries. Updated the site version from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:27:43.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Results posted on 2026-01-26. The page now shows updated Cohort 2 treatment details (Nivolumab + Ipilimumab dosing with 1 mg/kg and 3 mg/kg regimens, followed by Nivolumab monotherapy, and External Beam RT options) and adds a new primary outcome (Number of Participants Without Disease Progression at Six Months).
    Difference
    4%
    Check dated 2026-01-28T06:21:54.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision v3.3.4 replaces the previous Revision v3.3.3 on the page, representing a minor platform update that does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:17:21.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    A Locations section is now shown with Massachusetts listed as a site. The page revision updated from v3.3.2 to v3.3.3, and the HHS Vulnerability Disclosure link as well as the older Massachusetts Locations entry were removed.
    Difference
    0.2%
    Check dated 2025-12-23T22:37:12.000Z thumbnail image

Stay in the know with updates to Nivolumab for Recurrent Meningioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Recurrent Meningioma Clinical Trial page.